CTRI/2020/07/026399尚未招募未知
A study to assess the efficacy of subsartorial adductor canal with femoral nerve block for post operative analgesia after knee surgery
Azeezia Medical Collage0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of ASA physical status 1-2, aged between 18-80 years, undergoing knee surgery
排除标准
- •Patients with
- •1) History of chronic pain defined as daily or almost daily (most days of a week) use of opioids for >three months
- •2) History of peripheral neuropathy or neurologic and/ deficits,
- •3)Infection at the site of injections,
- •4)Coagulopathies
- •5)Refusal to the use of peripheral nerve blocks,
- •6)Contraindications to spinal or epidural anaesthesia
- •7)H/o of drug allergies
研究者
相似试验
尚未招募
不适用
A study to compare the effectiveness of oral fexofenadine combined with topical treatment vs topical treatment alone in treatment of childhood atopic dermatitisCTRI/2019/12/022332PGIMER Chandigarh
已完成
2 期
A phase II study evaluating the effect of the addition of lenalidomide to R-CHOP for patients with newly diagnosed MYC positive DLBCL and BCL-U.Diffuse Large B Cell Lymophoma10025320NL-OMON47340HOVO82
招募中
不适用
A phase II study evaluating the effect of the addition of lenalidomide to R-CHOP for patients with newly diagnosed MYC positive DLBCL and BCL-U.Diffuse large B cell lymphoma, DLBCL, BCL-U, MYCNL-OMON24704HOVO72
进行中（未招募）
1 期
A phase II study evaluating the effect of the addition of lenalidomide to R-CHOP for patients with newly diagnosed MYC positive DLBCL and BCLMYC positive diffuse large B cell lymphoma and Burkitt lymphomaMedDRA version: 20.0Level: HLTClassification code 10012819Term: Diffuse large B-cell lymphomasSystem Organ Class: 100000004943MedDRA version: 20.0Level: HLTClassification code 10006596Term: Burkitt's lymphomasSystem Organ Class: 100000004943EUCTR2014-002654-39-BEHOVON Foundation85
进行中（未招募）
1 期
A phase II study evaluating the effect of the addition of lenalidomide to R-CHOP for patients with newly diagnosed MYC positive DLBCL and BCLEUCTR2014-002654-39-NLHOVON Foundation85